165 related articles for article (PubMed ID: 8722493)
1. Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the rat.
Yu H; Liu Y; Hacksell U; Lewander T
J Pharm Pharmacol; 1996 Jan; 48(1):41-5. PubMed ID: 8722493
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
Yu H; Lewander T
Eur Neuropsychopharmacol; 1997 Aug; 7(3):165-72. PubMed ID: 9213074
[TBL] [Abstract][Full Text] [Related]
3. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
4. (R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel 5-HT1A receptor agonists.
Yu H; Liu Y; Hacksell U; Lewander T
Eur J Pharmacol; 1993 Jan; 231(1):69-76. PubMed ID: 8444282
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic and pharmacokinetic studies in rats of S-8-(2-Furyl)- and R-8-phenyl-2-(di-n-propylamino) tetralin, two novel 5-HT1A receptor agonists in-vitro with different properties in-vivo.
Yu H; Liu Y; Li HB; Martin AR; Hacksell U; Lewander T
J Pharm Pharmacol; 1997 Feb; 49(2):169-77. PubMed ID: 9055190
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of (R)-, (R, S)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on hippocampal serotonin release and induction of hypothermia in awake rats.
Yoshitake T; Kehr J
Life Sci; 2004 Apr; 74(23):2865-75. PubMed ID: 15050424
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective high-performance liquid chromatographic analysis of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin. Application to a pharmacokinetic-pharmacodynamic study in rats.
Zuideveld KP; Treijtel N; Van der Graaf PH; Danhof M
J Chromatogr B Biomed Sci Appl; 2000 Jan; 738(1):67-73. PubMed ID: 10778927
[TBL] [Abstract][Full Text] [Related]
8. Counteraction of the rapid tolerance to 8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia in rats by activation of the GABAA receptor-chloride channel complex.
Kelder D; Ross SB
Pharmacol Toxicol; 2002 Jan; 90(1):14-9. PubMed ID: 12005107
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioavailability after intramuscular injection of the 5-HT
Pfitzer S; Woodward AP; Laubscher L; Warren K; Vaughan-Higgins R; Raath JP; Laurence M
J Vet Pharmacol Ther; 2019 May; 42(3):251-257. PubMed ID: 30656714
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity to 8-hydroxy-2-(di-n-propylamino)tetralin-induced corticosterone secretion and hypothermia between Sprague-Dawley rats from different breeding colonies.
Kelder D; Ross SB
Pharmacol Toxicol; 2001 Dec; 89(6):295-300. PubMed ID: 11903954
[TBL] [Abstract][Full Text] [Related]
11. The ontogeny of tolerance to the 5-HT1A agonist 8-OH-DPAT: a study in the rat.
Johansson-Wallsten CE; Meyerson BJ
Neuropharmacology; 1994; 33(3-4):325-30. PubMed ID: 7984269
[TBL] [Abstract][Full Text] [Related]
12. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.
Sonesson C; Boije M; Svensson K; Ekman A; Carlsson A; Romero AG; Martin IJ; Duncan JN; King LJ; Wikström H
J Med Chem; 1993 Oct; 36(22):3409-16. PubMed ID: 8230131
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
Casanovas JM; Vilaró MT; Mengod G; Artigas F
J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
[TBL] [Abstract][Full Text] [Related]
14. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia.
Zuideveld KP; Treijtel N; Maas HJ; Gubbens-Stibbe JM; Peletier LA; van Der Graaf PH; Danhof M
J Pharmacol Exp Ther; 2002 Jan; 300(1):330-8. PubMed ID: 11752133
[TBL] [Abstract][Full Text] [Related]
15. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat.
Eltayb A; Lindblom S; Oerther S; Ahlenius S
Acta Physiol Scand; 2001 Jul; 172(3):205-9. PubMed ID: 11472307
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia.
Bill DJ; Knight M; Forster EA; Fletcher A
Br J Pharmacol; 1991 Aug; 103(4):1857-64. PubMed ID: 1833017
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia.
Kline AE; Massucci JL; Dixon CE; Zafonte RD; Bolinger BD
J Neurotrauma; 2004 Feb; 21(2):175-85. PubMed ID: 15000758
[TBL] [Abstract][Full Text] [Related]
18. (S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.
Stjernlöf P; Gullme M; Elebring T; Andersson B; Wikström H; Lagerquist S; Svensson K; Ekman A; Carlsson A; Sundell S
J Med Chem; 1993 Jul; 36(15):2059-65. PubMed ID: 8340910
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
Sugimoto Y; Kimura I; Watanabe Y; Yamada J
Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
[TBL] [Abstract][Full Text] [Related]
20. Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats.
Martin GE; Lis EV
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):251-61. PubMed ID: 3159366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
